Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Sanofi Consumer Healthcare India Ltd.
₹4,689.70
Invest in SANOFICONR with up to 3.33x margin.
Trade with MTF₹4678.10
₹4740.50
₹3975.00
₹5894.50
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 229.20 | 251 | 233.90 | 220.90 | 172.60 |
| Operating Expense | 140.40 | 161.20 | 148.90 | 150.70 | 108.60 |
| Operating Profit | 88.80 | 89.80 | 85 | 70.20 | 64 |
| Depreciation | 3.20 | 3.40 | 3.30 | 3 | 2 |
| Interest | 0.50 | 0.50 | 0.60 | 0.50 | 0.40 |
| Tax | 22.90 | 24 | 21.20 | 18.20 | 16.80 |
| Net Profit | 67.80 | 66.50 | 62.90 | 60.70 | 50 |
₹4689.70
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 60.4 | 60.4 | 71.3 | 71.3 | 71.3 | 71.3 |
| FII | 4.4 | 4.5 | 3.2 | 2.9 | 2.8 | 2.8 |
| DII | 25.4 | 25.5 | 16.9 | 17.3 | 17.4 | 17.5 |
| Public | 9.8 | 9.6 | 8.6 | 8.6 | 8.6 | 8.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.79 K | 2.91 K | 61.62% |
| Week | 6.5 K | 11.5 K | 56.54% |
| 1 Month | 7.82 K | 12.62 K | 61.94% |
| 6 Month | 6.18 K | 21.27 K | 29.07% |
Positive Breakout First Resistance ( LTP > R1)
Companies with no Debt
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Mid-range Performer (DVM)
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 4 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 17 Apr, 2025 | 55 | FINAL | 17 Apr, 2025 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹1,699.90 | ₹724.95 | ₹953.50 | ₹1,145.70 | ₹519.30 |
| % Change | 0.91% | 7.66% | 0.39% | 3.13% | -0.14% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | - | ₹1,598.19 | ₹649.50 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | - | ₹206.20 | ₹115.38 | ₹255.19 |
| PE TTM | 57.20 | - | 78.90 | 43.30 | 31.80 |
| 1 Year Return | 63.07 | 9.63 | 103.31 | 111.14 | -6.77 |
| ROCE | 31.54 | 34.78 | 34.76 | 15.60 | 11.40 |
Blue Jet Healthcare Ltd
₹ 445.35
+0.97%
Concord Biotech Ltd.
₹ 1156.70
+0.29%
Aarti Pharmalabs Ltd.
₹ 727.80
+2.06%
Supriya Lifescience Ltd.
₹ 783.45
+1.21%
Alivus Life Sciences Ltd.
₹ 1041.50
+0.24%
Cohance Lifesciences Ltd.
₹ 428.75
+2.44%
Eris Lifesciences Ltd.
₹ 1345.10
+0.10%
Syngene International Ltd.
₹ 465.80
+0.86%
Alembic Pharmaceuticals Ltd.
₹ 757.50
+0.24%
Sun Pharma Advanced Research Company Ltd.
₹ 226.41
+7.93%
Strides Pharma Science Ltd.
₹ 1176.60
+2.03%
Granules India Ltd.
₹ 760.30
+1.11%
FDC Ltd.
₹ 369.70
-0.95%
Shilpa Medicare Ltd.
₹ 510.85
+4.20%
Jubilant Pharmova Ltd.
₹ 970.00
-3.61%
Caplin Point Laboratories Ltd.
₹ 2067.00
+1.92%
Marksans Pharma Ltd.
₹ 218.90
+3.32%
Sanofi India Ltd.
₹ 3159.40
-0.12%
Procter & Gamble Health Ltd.
₹ 5601.00
+0.86%
Jeena Sikho Lifecare Ltd.
₹ 628.00
-3.35%
By signing up I certify terms, conditions & privacy policy